The Global Market for EPA/DHA Omega-3 Products

September 2012 | 53 pages | ID: G1D811C5FE9EN
Packaged Facts

Abstracts

Packaged Facts projects the market value of EPA/ DHA omega-3 packaged products to reach $34.7 billion in 2016, representing a compound annual growth rate (CAGR) of 6.4% over 2011. Expanding public awareness of EPA/DHA omega-3 health benefit through positive media coverage of scientific research findings, as well as developments in regulatory markets, will contribute significantly to continued growth in the global market for EPA/DHA omega-3 products. Other factors that will continue to create a positive growth environment for EPA/DHA omega-3 products include:

• Consumer interest in functional food and fortified product line expansions;
• Increasing demand for fortified infant formula due to population growth and rising middle class in emerging economies;
• Continued popularity of EPA/DHA omega-3 nutritional supplement products, including krill oil and vegetarian algae-based supplements;
• Introduction of pharmaceutical-grade products into South America and approval of generic forms in existing markets;
• Expanding clinical nutrition market opportunities for disease- and disorder-specific formula applications, created through additional R & D and aggressive marketing by ingredient suppliers;
• Premiumization of pet foods due to humanization of companion animals.

This report, based on research commissioned by the Global Organization for EPA and DHA Omega-3 (GOED) and featured at the GOED Exchange 2012 conference in Boston in June 2012, focuses on the market for EPA / DHA omega-3 packaged products by category and global region. The products included in this study are those fortified with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Excluded from scope of this study are non-fortified fish/ fish products as well as products that only contain alpha linoleic acid (ALA) omega-3.

The geographic scope of this report is global, broken out into four regions: North America (United States and Canada); Europe (Scandinavia, Western Europe, Eastern Europe and Russia); Asia Pacific (China, Japan, South and Southeast Asia, Australia, New Zealand and Oceania); and Rest of World (Latin America, Middle East and Africa). Six categories of packaged consumer products are covered by this report: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition (enteral and parenteral) products; and pet food, treats and supplements.

The base year for market sizing is 2011, with projections for 2016. All market size figures and projections are calculated in U.S. dollars.

Contents

CHAPTER 1: EXECUTIVE SUMMARY

  Scope of Report
  Report Methodology
Market Size and Composition
    Market Composition by Geographic Region
    Table 1-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011
    Figure 1-1: EPA/DHA Omega-3 Products: Global Market Share by Region, 2011
    Market Composition by Product Category
    Table 1-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011
    Figure 1-2: EPA/DHA Omega-3 Products: Global Market Share by Category, 2011
  Factors to Market Growth
  Projected Market Growth
    Table 1-3: Global Market for EPA/DHA Omega-3 Products, 2011 vs. 2016
    Projected Growth by Geographic Region
    Table 1-4: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016
    Figure 1-3: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016
    Projected Growth by Product Category
    Table 1-5: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2016
    Figure 1-4: EPA/DHA Omega-3 Products: Global Market Share by Category, 2016

CHAPTER 2: MARKET REVIEW

  Global Market Size and Composition
     Table 2-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011
     Figure 2-1: Share of EPA/DHA Omega-3 Products by Global Region, 2011
     Market Composition by Product Category
     Table 2-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011
     Figure 2-2: Share of EPA/DHA Omega-3 Product Sales by Global Region, 2011
  Category Focus: Infant Formula
     Category Value by Region
     Table 2-3: DHA/ARA-Fortified Infant Formulas: Global Market Size and Share by Region, 2011
     Figure 2-3: Share of DHA/ARA-Fortified Infant Formula Sales by Global Region, 2011
     U.S. Market Trends
     Emerging Market Trends
     Figure 2-4: Birth Rates by Global Regions, 2010
     Figure 2-5: Birth Rates for Selected Countries, 2010-2015
  Category Focus: Fortified Foods and Beverages
     Category Value by Region
     Table 2-4: EPA/DHA-Fortified Foods & Beverages: Global Category Size and Share by Region, 2011
     Figure 2-6: Category Share of EPA/DHA-Fortified Food & Beverage Sales by Global Region, 2011
     Dairy Products
     Beverages and Juices
     Baby Food and Pediatric Juices
     Breads and Bakery
     Processed Meats
     Cooking Oils
     Figure 2-7: Estimated Average Daily Intakes of EPA/DHA by Country (in mg/day based on 2,000 kCAL diet)
     Prepared Products
     Other Foods
  Category Focus: Nutritional Supplements
    Category Value by Global Region
    Table 2-5: EPA/DHA Nutritional Supplements: Global Category Size and Share by Region, 2011
    Figure 2-8: Category Share of EPA/DHA Omega-3 Nutritional Supplements by Global Region, 2011
    Category and Regional Trends
  Category Focus: Pharmaceuticals
    Lovaza
    Epadel
    Category Value by Region
    Table 2-6: EPA/DHA Pharmaceuticals: Global Category Size and Share by Region, 2011
    Figure 2-9: Share of EPA/DHA Pharmaceutical Sales by Global Region, 2011
    Category Perspective
    Table 2-7: Omega-3 Fatty Acid Pharmaceutical Products in Development
    Source: GOED (Global Organization for EPA and DHA Omega-3)
    Table 2-8: Potential Generic Drug Manufacturer Market Entry
  Category Focus: Clinical Nutrition
    Category Value by Region
    Table 2-9: Clinical Nutrition Products with EPA/DHA: Global Category Size and Share by Region, 2011
    Figure 2-10: Share of Sales for Clinical Nutrition Products with EPA/DHA by Global Region, 2011
    Established and Emerging Markets
    Figure 2-11: Population Aged 65 or Older by Country: 2010 vs. 2015
  Category Focus: Pet Food, Treats and Supplements
    Category Value by Region
    Table 2-10: EPA/DHA-Fortified Pet Food, Treats, and Supplements: Global Category Size and Share by Region, 2011
    Figure 2-12: Share of Sales for Pet Food, Treats, or Supplements with EPA/DHA by Global Region, 2011
    Market Scales Up and Expands Out
    Projected Sales and Shares by Geographic Region
    Table 2-11: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016
     Figure 2-13: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016
     Figure 2-14: Projected CAGR for EPA/DHA Omega-3 by Region, 2011-2016
     Projected Sales and Shares by Product Category
     Figure 2-15: Projected Global Market Shares for EPA/DHA Omega-3 Products by Category, 2016
     Table 2-12: Projected Market for DHA/ARA-Fortified Infant Formula: Overall and by Global Region, 2011-2016
     Table 2-13: Projected Market for EPA/DHA-Fortified Food & Beverages: Overall and by Global Region, 2011-2016
     Table 2-14: Projected Market for EPA/DHA Nutritional Supplements: Overall and by Global Region, 2011-2016
     Table 2-15: Projected Market for EPA/DHA Pharmaceuticals: Overall and by Global Region, 2011-2016
     Table 2-16: Projected Market Clinical Nutrition Products with EPA/DHA: Overall and by Global Region, 2011-2016
     Table 2-17: Projected Market for EPA/DHA-Fortified Pet Food, Treats, and Supplements: Overall and by Global Region, 2011-2016
  Summary of Factors to Future Growth